NAV
$80.29
AUM
$465.2M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.94
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.35% | +3.31% | +8.47% | +21.17% | +19.53% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML | ASML Holding NV ADR | 1.12% |
| 2 | HSBC | HSBC Holdings PLC ADR | 1.06% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.06% |
| 4 | NVS | Novartis AG ADR | 0.84% |
| 5 | 9984.T | SoftBank Group Corp | 0.79% |
| 6 | RY | Royal Bank of Canada | 0.79% |
| 7 | CLS.TO | Celestica Inc Ordinary Shares (Subordinate Voting) | 0.71% |
| 8 | IFX.DE | Infineon Technologies AG | 0.64% |
| 9 | DG.PA | Vinci SA | 0.61% |
| 10 | UCG.MI | UniCredit SpA | 0.60% |
The fund invests primarily in a diverse group of non-U.S. companies across countries, market sectors and industry groups. It may invest in companies of all market capitalizations. Under normal market conditions, the fund will invest at least 80% of its assets in equity securities. The fund may invest in securities that are denominated in foreign currencies and may also invest in foreign securities that are represented in the U.S. and other securities markets by American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs), and other similar depositary arrangements.
Inception Date: 2022-03-15